Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. CEO Brian Markison will deliver a presentation on Tuesday, September 9, at 7:00 a.m. ET.
Investors and interested parties can access the live webcast through the Investors section of Lantheus.com. The presentation recording will remain available on the company's website for a minimum of 30 days following the live event.
Lantheus Holdings (NASDAQ: LNTH), azienda leader nel settore dei radiofarmaci, ha annunciato la sua partecipazione alla 23ª Conferenza Annuale Globale sul Settore Sanitario di Morgan Stanley. Il CEO Brian Markison terrà una presentazione martedì 9 settembre alle 7:00 ET.
Investitori e interessati potranno seguire la diretta tramite la sezione Investors di Lantheus.com. La registrazione della presentazione resterà disponibile sul sito della società per almeno 30 giorni dopo l'evento live.
Lantheus Holdings (NASDAQ: LNTH), una empresa líder en radiofármacos, ha anunciado su participación en la 23ª Conferencia Anual Global de Salud de Morgan Stanley. El CEO Brian Markison ofrecerá una presentación el martes 9 de septiembre a las 7:00 a.m. ET.
Los inversores e interesados podrán acceder a la transmisión en vivo desde la sección Investors de Lantheus.com. La grabación de la presentación permanecerá disponible en la web de la compañía durante al menos 30 días tras el evento en directo.
Lantheus Holdings (NASDAQ: LNTH), 방사성의약품 분야의 선도 기업이 다가오는 모건스탠리 제23회 연례 글로벌 헬스케어 콘퍼런스에 참여한다고 발표했습니다. CEO 브라이언 마키슨(Brian Markison)이 9월 9일 화요일 오전 7:00(동부시간)에 발표를 진행합니다.
투자자 및 관심 있는 분들은 Lantheus.com의 Investors 섹션을 통해 생중계를 시청할 수 있습니다. 발표 녹화는 라이브 이벤트 후 최소 30일 동안 회사 웹사이트에 게재됩니다.
Lantheus Holdings (NASDAQ: LNTH), société leader dans les radiopharmaceutiques, a annoncé sa participation à la 23e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Le CEO Brian Markison prononcera une présentation le mardi 9 septembre à 7h00 (HE).
Les investisseurs et les personnes intéressées peuvent accéder au webcast en direct via la rubrique Investors de Lantheus.com. L'enregistrement de la présentation restera disponible sur le site de la société pendant au moins 30 jours après l'événement en direct.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Radiopharma-Unternehmen, hat seine Teilnahme an der bevorstehenden 23. Morgan Stanley Annual Global Healthcare Conference angekündigt. CEO Brian Markison wird am Dienstag, den 9. September, um 7:00 Uhr ET eine Präsentation halten.
Investoren und Interessierte können das Live-Webcast über den Bereich Investors auf Lantheus.com verfolgen. Die Aufzeichnung der Präsentation bleibt nach der Live-Veranstaltung für mindestens 30 Tage auf der Unternehmenswebsite verfügbar.
- None.
- None.
BEDFORD, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Tuesday, September 9.
To access the live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden and Switzerland, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors access Lantheus (LNTH) Morgan Stanley conference presentation?
Who will represent Lantheus (LNTH) at the Morgan Stanley Healthcare Conference?
How long will the Lantheus (LNTH) Morgan Stanley conference presentation be available for replay?
